COMPLETE VERSUS FRAGMENTED, I-131-LABELED AND Y-90-LABELED ANTIBODIESFOR RADIOIMMUNOTHERAPY (RAIT) OF CEA-EXPRESSING CANCERS - INFLUENCE OF DOSE-RATE AND RENAL ACCRETION ON TOXICITY AND ANTI-TUMOR-EFFICACY
Tm. Behr et al., COMPLETE VERSUS FRAGMENTED, I-131-LABELED AND Y-90-LABELED ANTIBODIESFOR RADIOIMMUNOTHERAPY (RAIT) OF CEA-EXPRESSING CANCERS - INFLUENCE OF DOSE-RATE AND RENAL ACCRETION ON TOXICITY AND ANTI-TUMOR-EFFICACY, The Journal of nuclear medicine, 38(5), 1997, pp. 107-107